Epilepsy Trial, Recruiting NCT05559749 Sponsor: Wake Forest University Health Sciences Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05559749
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older, of any gender
  • People who have been diagnosed with epilepsy, based on a neurologist's assessment or brainwave test (EEG) results
  • People who are experiencing symptoms of anxiety or depression
  • People who are currently receiving neurological care at Atrium Health
  • People who are willing to follow all study procedures and sign a consent form

Who may not be able to join:

  • People who are currently taking part in another treatment or intervention study
  • People whose cognitive difficulties would prevent them from completing anxiety and depression questionnaires — whether on paper, electronically, or through an interview
  • People who have a serious medical condition where life expectancy is less than 6 months
  • People who are already being actively treated by a psychiatrist
  • People who are currently having thoughts of suicide
  • People who have previously attempted suicide AND are currently receiving ongoing therapy, OR have seen a psychiatrist in the past year
  • People who have attempted suicide in the past year AND are currently prescribed two or more psychiatric medications (not just for sleep), AND where the trial investigators do not consider collaborative care to be appropriate
  • People with ongoing unstable drug or alcohol misuse

Important: Always verify eligibility with the trial site directly before applying.


Note: A separate part of this trial (called the sustainability supplement) also allows participation for people who have completed the control arm of a related study, or people who meet similar criteria but have a diagnosis of functional neurological disorder with seizures rather than epilepsy. Please confirm details about this with the trial site directly.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Heidi M Munger Clary, MPH, Wake Forest University Health Sciences

Phone: 336.716.9632

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 May 2023
Est. completion
19 February 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

change in emotional quality of life subscale of the Quality of Life in Epilepsy Inventory (QOLIE-31) - between two groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov